Antisense Targets to Enhance Hormone and Cytotoxic Therapies in Advanced Prostate Cancer
Journal:
Current Drug Targets
Volume:
4
Page:
209-221
Author(s):
Martin Gleave, Colleen Nelson and Kim Chi
Par-4 for Molecular Therapy of Prostate Cancer
Journal:
Current Drug Targets
Volume:
4
Page:
223-230
Author(s):
James Butler and Vivek M. Rangnekar
From TGF-β to Cancer Therapy
Journal:
Current Drug Targets
Volume:
4
Page:
243-250
Author(s):
Xuemei Huang and Chung Lee
Survivin: Role in Normal Cells and in Pathological Conditions
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
131-152
Author(s):
L. O'Driscoll, R. Linehan and M. Clynes
Intraperitoneal Oncolytic and Tumor Vaccination Therapy with Replication-Competent Recombinant Virus: The Herpes Paradigm
Journal:
Current Gene Therapy
Volume:
3
Page:
113-125
Author(s):
George Coukos, Maria Cecilia Courreges and Fabian Benencia
Tumoral Drug Metabolism: Perspectives and Therapeutic Implications
Journal:
Current Drug Metabolism
Volume:
4
Page:
131-149
Author(s):
M. M. Doherty and M. Michael
Pharmacodynamics of Radiolabelled Anticancer Drugs for Positron Emission Tomography
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
931-944
Author(s):
O. Clyde Hutchinson, David R. Collingridge, Henryk Barthel, Pat. M. Price and Eric O. Aboagye
Cytokine Gene Polymorphism in Heart Transplantation: A Review
Journal:
Current Genomics
Volume:
4
Page:
205-215
Author(s):
F. J. Bijlsma, A. H. Bruggink, F. H.J. Gmelig-Meyling and R.A. de Weger
Rational Drug Development Using Gene-Targeted Agents and Their Application in Anti-Gene Radiotherapy
Journal:
Current Genomics
Volume:
4
Page:
275-294
Author(s):
Thomas A. Winters, Elzbieta Pastwa, Kamal Datta and Ronald D. Neumann
ACE Inhibitors and AII Receptor Antagonists in the Treatment and Prevention of Bone Marrow Transplant Nephropathy
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
737-749
Author(s):
J. E. Moulder, B. L. Fish and E. P. Cohen